Over that period, the managers sold longtime holdings DexCom DXCM and Lululemon Athletica ... and in late 2017 it was heavy on non-US stocks just as US stocks began to outperform.

The pair met while working in Donaghy’s shoe shop ... Dexcom G7 continuous glucose monitoring (CGM) system helps manage these challenges by sending alerts straight to our mobile phones to alert ...

Holdings such as MSCI, DexCom, and CoStar were all purchased more ... The firm continues to integrate with sustainable investing shop Hermes Investment Management, which it acquired in 2021.

DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...

Fintel reports that on February 3, 2025, Redburn Atlantic upgraded their outlook for DexCom (NasdaqGS:DXCM) from Neutral to ...

Redburn Atlantic upgraded DexCom (DXCM) to Buy from Neutral with a price target of $115, up from $85. The company is positioned to benefit from ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2024 investor ...

DexCom Inc. closed 38.30% below its 52-week high of $142.00, which the company achieved on March 26th.

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period. DexCom develops continuous glucose monitoring (CGM) devices that help ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A better-than-expected third-quarter 2024 performance and a series of favorable coverage ...

DexCom (NASDAQ:DXCM) shares popped 6% premarket on Monday after the company set its financial forecast for 2025, projecting adjusted gross profit margin of around 64% – 65% on revenue of $4.60B ...

Dexcom (DXCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on January 13. Analyst Mike Kratky from Leerink Partners maintained a Buy rating on the ...